1-46394398-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001441.3(FAAH):c.50C>T(p.Ala17Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000107 in 1,519,914 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001441.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FAAH | NM_001441.3 | c.50C>T | p.Ala17Val | missense_variant | 1/15 | ENST00000243167.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FAAH | ENST00000243167.9 | c.50C>T | p.Ala17Val | missense_variant | 1/15 | 1 | NM_001441.3 | P1 | |
FAAH | ENST00000468718.5 | n.70C>T | non_coding_transcript_exon_variant | 1/5 | 3 | ||||
FAAH | ENST00000493735.5 | n.28C>T | non_coding_transcript_exon_variant | 1/8 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000920 AC: 14AN: 152104Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000286 AC: 37AN: 129392Hom.: 0 AF XY: 0.000231 AC XY: 17AN XY: 73512
GnomAD4 exome AF: 0.000109 AC: 149AN: 1367810Hom.: 0 Cov.: 30 AF XY: 0.0000989 AC XY: 67AN XY: 677524
GnomAD4 genome AF: 0.0000920 AC: 14AN: 152104Hom.: 0 Cov.: 33 AF XY: 0.0000673 AC XY: 5AN XY: 74316
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 19, 2022 | The c.50C>T (p.A17V) alteration is located in exon 1 (coding exon 1) of the FAAH gene. This alteration results from a C to T substitution at nucleotide position 50, causing the alanine (A) at amino acid position 17 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at